<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/feed/crbs/issue-1083.rss">
<title>Volume 7, Issue 2 (2017) | Current Research in Biostatistics</title>
<description>Volume 7, Issue 2 (2017) | Current Research in Biostatistics</description>
<link>https://thescipub.com/crbs/issue/1083</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@thescipub.com"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub.com/crbs/amjbsp.2017.30.38"/><rdf:li rdf:resource="https://thescipub.com/crbs/amjbsp.2017.39.53"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub.com/crbs/amjbsp.2017.30.38">
    <title><![CDATA[The Extent of Community Awareness Using Natural Element’s Instead of Using Chemical Drugs]]></title>
    <link>https://thescipub.com/crbs/amjbsp.2017.30.38</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Biostatistics, Published online: 25 October 2017; <a href="https://thescipub.com/crbs/amjbsp.2017.30.38">doi:10.3844/amjbsp.2017.30.38</a></p>Alternative medicine it is a medicine that is not taught in traditional medicine. It is based on ancient historical foundations and different experiments in treatment without building it on the basis ...]]></content:encoded>
    <dc:title><![CDATA[The Extent of Community Awareness Using Natural Element’s Instead of Using Chemical Drugs]]></dc:title><dc:creator>Meliz  Yuvalı</dc:creator><dc:creator>Ismail  Bakır</dc:creator><dc:creator>Ilker  Etikan</dc:creator><dc:identifier>doi:10.3844/amjbsp.2017.30.38</dc:identifier>
    <dc:source>Current Research in Biostatistics, Published online: 2017-10-25; | doi:10.3844/amjbsp.2017.30.38</dc:source>
    <dc:date>2017-10-25</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/amjbsp.2017.30.38</prism:doi>
    <prism:url>https://thescipub.com/crbs/amjbsp.2017.30.38</prism:url>
    </item><item rdf:about="https://thescipub.com/crbs/amjbsp.2017.39.53">
    <title><![CDATA[ATLCEP: A New Integrated Design that Encompasses the Safety and Efficacy Objectives of Phase I/II Trials]]></title>
    <link>https://thescipub.com/crbs/amjbsp.2017.39.53</link>
    <content:encoded>
        <![CDATA[<p>Current Research in Biostatistics, Published online: 7 April 2018; <a href="https://thescipub.com/crbs/amjbsp.2017.39.53">doi:10.3844/amjbsp.2017.39.53</a></p>Several designs, such as designs to find the optimal biological dose, the Eff-Tox design and seamless Phase I/II designs, have been proposed to evaluate both drug toxicity and efficacy as alternatives...]]></content:encoded>
    <dc:title><![CDATA[ATLCEP: A New Integrated Design that Encompasses the Safety and Efficacy Objectives of Phase I/II Trials]]></dc:title><dc:creator>Revathi  Ananthakrishnan</dc:creator><dc:creator>Stephanie  Green</dc:creator><dc:creator>Mark  Chang</dc:creator><dc:creator>Gheorghe  Doros</dc:creator><dc:creator>Joseph  Massaro</dc:creator><dc:creator>Daniel  Li</dc:creator><dc:creator>Michael  LaValley</dc:creator><dc:identifier>doi:10.3844/amjbsp.2017.39.53</dc:identifier>
    <dc:source>Current Research in Biostatistics, Published online: 2018-04-07; | doi:10.3844/amjbsp.2017.39.53</dc:source>
    <dc:date>2018-04-07</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/amjbsp.2017.39.53</prism:doi>
    <prism:url>https://thescipub.com/crbs/amjbsp.2017.39.53</prism:url>
    </item></rdf:RDF>